This document discusses key current and future regulatory challenges in the medical device and IVD sector. Regulations are constantly evolving as the types of products in these sectors expand unpredictably. In the EU, directives have been amended over time and new regulations will be introduced. In the US, the 21st Century Cures Act aims to streamline FDA regulations but may allow unsafe devices on the market. The new EU regulations will increase requirements for clinical evaluation, post-market surveillance, and Notified Body involvement for most IVDs. Distinguishing medical software and ensuring data protection and quality submissions will also be challenges going forward.